2-Amino-4,6-Dimethoxy-1,3,5-Triazine

We are 2-Amino-4,6-Dimethoxy-1,3,5-Triazine CAS:16370-63-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 16370-63-1
Product Name: 2-Amino-4,6-Dimethoxy-1,3,5-Triazine
Other Name:
2-Amino-4,6-Dimethoxy-1,3,5-Triazine
4,6-dimethoxy-1,3,5-triazin-2-amine
 
Density: 1.307 g/cm3
Boiling Point: 338.8ºC at 760 mmHg
Melting Point: 220-222ºC
Molecular Formula: C5H8N4O2
Molecular Weight: 156.14300
Flash Point: 158.7ºC
Exact Mass: 156.06500
PSA: 83.15000
LogP: 0.05220
Vapour Pressure: 9.6E-05mmHg at 25°C
Index of Refraction: 1.551
 
Specification
Appearance: White crystals
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Cinosulfuron CAS: 94593-91-6.
Be used as pesticide intermediate, mainly used to synthesize herbicide Cinosulfuron.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-Amino-4,6-Dimethoxy-1,3,5-Triazine


Related News: Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.5-cloro-2,4-difluoroanilina CAS:348-65-2 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.5-[2-(methylamino)-5-nitroanilino]-5-oxopentanoic acid CAS:91644-13-2 China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.Ácido trifluorometanosulfónico CAS:1493-13-6 China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.Developing countries such as China and India have good foundations for undertaking global industrial transfers because of their comparative advantages. With the continuous improvement of China’s fine chemical technology level, the types of products and market shares in China’s undertaking industrial transfer have gradually increased.

Related Products
Product Name
3-Bromo-2-fluoro-5-methylpyridine View Details
2,2,3,3,4,4,4-Heptafluoro-1-butanol Cas:375-01-9 View Details
2-Fluoro-3-methylBenzonitrile View Details
4,4′-METHYLENEBIS[N-SEC-BUTYLANILINE] (MDBA) manufacturer Methyl 4-(2-methoxy-2-oxoethyl)-3-nitrobenzoate manufacturer (Methylthio)methylpyrazine manufacturer N-(3-chloro-4-fluorophenyl)-6-nitro-7-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine manufacturer N-(2-Amino-4,6-dichloro-5-pyrimidinyl)formamide manufacturer